Miltenyi Biotec inaugurates India’sfirst cell andgene therapy centre of excellence in Hyderabad
March 6th, 2025, Hyderabad – Miltenyi Biotec, a global leader in cell and gene therapy (CGT) solutions, launched India’s first-everdedicated cell & gene therapy center-of-excellence (CoE) in Hyderabad. With this launch, Miltenyi Biotec reinforces its commitment to India. It also furthers the vision of the company to advance cutting-edge biotechnology and foster innovation in India’s rapidly growing life sciences sector.
Spanning 1,800 sqm in Genome Valley, India’s leading life sciences hub, MITC (Miltenyi innovation and technology center) is designed to advance cell and gene therapy development. It will foster innovation by integrating expertise, best practices, and cutting-edge technologies to combat diseases, including cancer. The facility features a showroom with advanced MACS® instruments, a CliniMACS Prodigy® platform for therapy development and manufacturing, and interactive training opportunities. It will serve as a collaborative hub, hosting seminars and workshops in immunology, stem cell biology, cancer, and other key areas.
MITC was inaugurated by Mr. Jayesh Ranjan, Special Chief Secretary for the Information Technology, Electronics & Communications (ITE&C), and Industries & Commerce Departments of the Government of Telangana and Dr. Kathrin Misera-Lang, Consul General (interim) of the Federal Republic of Germany to the Republic of India, Chennai. They were joined by Dr. Boris Stoffel, Chief Commercial Officer, Member of the Board, Miltenyi Biotec B.V. & Co. KG, Priya Hingorani, Managing Director, Miltenyi Biotec India, Mr. Shakti Nagappan, CEO of Telangana Lifesciences, and Hon. Ms. Amita Desai, Honorary Consul of the Federal Republic of Germany in Hyderabad.
Shri D Sridhar Babu, IT and Industries Minister of Telangana emphasized, “The inauguration of MITC showcases Telangana’s growing role as a hub for life sciences research and innovation. This facility strengthens our healthcare ecosystem and supports our vision of making Telangana a global leader in advanced biotechnology and healthcare solutions, particularly in cell and gene therapies.”
Mr. Jayesh Ranjan, Special Chief Secretary for the Information Technology, Electronics & Communications (ITE&C), and Industries & Commerce Departments of the Government of Telangana, stated, “The inauguration of Miltenyi Biotec’s center is a pivotal milestone in Telangana’s rise as a leading hub for life sciences research and innovation. This collaboration will strengthen our healthcare ecosystem and pave the way for groundbreaking advancements in cell and gene therapies. It will also unlock new avenues for employment and global investments, solidifying Telangana’s position as a leader in the life sciences and biotechnology sectors.”
Dr. Kathrin Misera-Lang, Consul General (interim) of the Federal Republic of Germany to the Republic of India, Chennai, remarked, “The launch of MITC in Hyderabad exemplifies the growing collaboration between India and Germany in biotechnology and healthcare. This state-of-the-art facility will make significant contributions to the field of cell and gene therapies, improving healthcare outcomes and strengthening India’s leadership in life sciences.”
Dr. Toon Overstijns, Managing Director, Miltenyi Biomedicine, Member of the Board, Miltenyi Biotec B.V. & Co. KG, stated, “MITC is a pivotal step in accelerating the global revolution in cell and gene therapies. We are dedicated to empowering the scientific community and transforming the lives of patients worldwide. This center reflects our ongoing commitment to advancing medical research and offering robust solutions in cell and gene therapy.
Dr. Boris Stoffel, Chief Commercial Officer, Member of the Board, Miltenyi Biotec B.V. & Co. KG, added, “MITC will drive advancements in biomedical research, supporting the scientific and medical community in developing new therapies for diseases with limited treatment options. It will enable close collaboration with researchers, physicians and industry providing them with the tools and expertise needed to deliver transformative therapies to patients.”
Speaking on the occasion, Priya Hingorani, Managing Director, Miltenyi Biotec India said, “We are thrilled to bring India’s first cell and gene therapy centre of excellence to Hyderabad, a city that has become a key hub for biotechnology and life sciences. This initiative reflects our dedication to empowering researchers and clinicians with world-class tools and expertise, driving innovation in cell and gene therapy to transform lives.”
Miltenyi Biotec has been leading biotechnology innovations for over 35 years, pioneering solutions that have beengroundbreaking innovations in cell and gene therapy. This launch underscores Miltenyi Biotec’s dedication to fosteringnext-generation therapies and contributing to India’s growing prominence in the global biotech landscape.
